Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Si-Bone Inc (NQ: SIBN )

13.60 -0.02 (-0.15%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 384,489
Open 13.57
Bid (Size) 5.460 (2)
Ask (Size) 14.48 (7)
Prev. Close 13.62
Today's Range 13.34 - 13.98
52wk Range 11.76 - 22.56
Shares Outstanding 33,271,020
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Analyst Ratings For SI-BONE
Via Benzinga
These Analysts Cut Their Forecasts On SI-BONE Following Q2 Results
Via Benzinga

Performance

YTD
-34.74%
-34.74%
1 Month
-14.68%
-14.68%
3 Month
+4.29%
+4.29%
6 Month
-14.20%
-14.20%
1 Year
-34.55%
-34.55%

More News

Read More
SIBN Stock Earnings: SI-BONE Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
7 Leading MedTech Stocks for Next-Gen Health Solutions
Via InvestorPlace
A Closer Look at 6 Analyst Recommendations For SI-BONE
Via Benzinga
SIBN Stock Earnings: SI-BONE Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Peeling Back The Layers: Exploring SI-BONE Through Analyst Insights
Via Benzinga
Beyond The Numbers: 4 Analysts Discuss SI-BONE Stock
Via Benzinga
Recap: SI-BONE Q4 Earnings
Via Benzinga
SI-BONE's Earnings Outlook
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Where SI-BONE Stands With Analysts
Via Benzinga
Earnings Scheduled For November 6, 2023
Via Benzinga
Analyst Ratings for SI-BONE
Via Benzinga
Analyst Ratings for SI-BONE
Via Benzinga
Earnings Preview: SI-BONE
Via Benzinga
The Latest Analyst Ratings for SI-BONE
Via Benzinga
Earnings Scheduled For February 26, 2024
Via Benzinga
What Analysts Are Saying About SI-BONE Stock
Via Benzinga
What 5 Analyst Ratings Have To Say About SI-BONE
Via Benzinga
Cantor Fitzgerald Maintains Overweight Rating for SI-BONE: Here's What You Need To Know
Via Benzinga
SI-BONE Poised For A Surge: Analyst Highlights Upside Potential With New Product Launches
Via Benzinga
Market Rally Finishes Strong; Regional Banks, Fed Rate Hike, Jobs Report, Apple In Focus: Weekly Review
Via Investor's Business Daily
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.